Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Milene Pereira Moreira"'
Autor:
Milene Pereira Moreira
Publikováno v:
Biblioteca Digital de Teses e Dissertações da UFMGUniversidade Federal de Minas GeraisUFMG.
Breast cancer is the second most common type of cancer worldwide and the most common among women. It is a heterogeneous disease, possibly due to the existence of a small population of cells in these tumors with stem cell properties, known as cancer s
Externí odkaz:
http://hdl.handle.net/1843/BUOS-97YG7V
Autor:
Fábio André Brayner, Luciana Maria Silva, Milene Pereira Moreira, Geovanni Dantas Cassali, Luiz Carlos Alves
Publikováno v:
European Biophysics Journal. 48:673-684
Triple negative breast cancer (TNBC) is a highly heterogeneous disease, which influences the therapeutic response and makes difficult the discovery of effective targets. This heterogeneity is attributed to the presence of breast cancer stem cells (BC
Autor:
Luciana Maria Silva, Milene Pereira Moreira, Letícia da Conceição Braga, Geovanni Dantas Cassali
Publikováno v:
Experimental Cell Research. 363:283-290
The cancer stem cell (CSC) concept is currently employed to explain the mechanism of multidrug resistance that is implicated in the reduced efficacy of many chemotherapeutic agents, consequently leading to metastatic spread and disease relapse. We se
Autor:
Milene Pereira Moreira
Publikováno v:
Repositório Institucional da UFMG
Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
O câncer de mama triplo-negativo (TNBC) caracteriza-se por uma alta heterogeneidade molecular e celular, o que influencia na resposta terapêutica e dificulta a descoberta de alvos efetivos. Essa heterogeneidade é atribuída à presença de célula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3056::b2506377c45ea90ab4cb471c1843f310
Autor:
Milene Pereira, Moreira, Letícia, da Conceição Braga, Geovanni Dantas, Cassali, Luciana Maria, Silva
Publikováno v:
Experimental cell research. 363(2)
The cancer stem cell (CSC) concept is currently employed to explain the mechanism of multidrug resistance that is implicated in the reduced efficacy of many chemotherapeutic agents, consequently leading to metastatic spread and disease relapse. We se